Vitamin D and Cardio-Metabolic Risk Factors in Overweight Adults: An Overview of the Evidence

Author(s): Ana Valer-Martinez, J. Alfredo Martinez, Carmen Sayon-Orea, Fabio Galvano, Giuseppe Grosso*, Maira Bes-Rastrollo*

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 22 , 2019


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: Several studies have suggested a potential association between low vitamin D serum levels and several pathological conditions apart from the well-known bone disorders. Thus, vitamin D insufficiency has been linked to cardiometabolic risk factors including obesity, insulin resistance, hypertension, dyslipidemia, as well as type 2 diabetes and cardiovascular disease.

Objective: This review intends to provide an overview of recent evidence from clinical studies on vitamin D [25- hydroxyvitamin D (25(OH)D)] and cardiometabolic risk factors in overweight adults. Furthermore, we also discussed potential mechanisms and limits of the retrieved results.

Methods: The search process was based on the selection of publications (RCT) listed in PubMed and Cochrane Library databases.

Results: Vitamin D status evidenced an inversely strong association with subcutaneous adipose tissue and visceral adiposity, but not significantly related to other bodyweight measures (i.e., body mass index). Studies have shown a potential inverse association of hypovitaminosis D with insulin resistance and cardiovascular risk factors.

Conclusion: The mechanisms by which vitamin D deficiency enhances adiposity, as well as putative association with metabolic syndrome features, remain still unclear. Further investigation would be required to conclude whether vitamin D has an independent role in preventing cardiometabolic disorders.

Keywords: 25-hydroxyvitamin D, body mass index, obesity, overweight, metabolic syndrome, cardiovascular disease.

[1]
Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas 2010; 65(3): 225-36.
[http://dx.doi.org/10.1016/j.maturitas.2009.12.013] [PMID: 20031348]
[2]
Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008; 3(5): 1535-41.
[http://dx.doi.org/10.2215/CJN.01160308] [PMID: 18525006]
[3]
Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-analysis. BMJ 2010; 341: C3691.
[http://dx.doi.org/10.1136/bmj.c3691] [PMID: 20671013]
[4]
Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: A trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014; 2(4): 307-20.
[http://dx.doi.org/10.1016/S2213-8587(13)70212-2] [PMID: 24703049]
[5]
Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009; 139(2): 329-34.
[http://dx.doi.org/10.3945/jn.108.093831] [PMID: 19106328]
[6]
Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017; 390(10113): 2627-42.
[http://dx.doi.org/10.1016/S0140-6736(17)32129-3] [PMID: 29029897]
[7]
Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care 2013; 36(5): 1422-8.
[http://dx.doi.org/10.2337/dc12-0962] [PMID: 23613602]
[8]
Manousopoulou A, Al-Daghri NM, Garbis SD, Chrousos GP. Vitamin D and cardiovascular risk among adults with obesity: A systematic review and meta-analysis. Eur J Clin Invest 2015; 45(10): 1113-26.
[http://dx.doi.org/10.1111/eci.12510] [PMID: 26222607]
[9]
Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index: A systematic review and meta-analysis. Obes Rev 2013; 14(5): 393-404.
[http://dx.doi.org/10.1111/obr.12016] [PMID: 23331724]
[10]
Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int 1988; 43(4): 199-201.
[http://dx.doi.org/10.1007/BF02555135] [PMID: 3145124]
[11]
Guo J, Lovegrove JA, Givens DI. A Narrative Review of The Role of Foods as Dietary Sources of Vitamin D of Ethnic Minority Populations with Darker Skin: The Underestimated Challenge. Nutrients 2019; 11(1)E81
[http://dx.doi.org/10.3390/nu11010081] [PMID: 30609828]
[12]
Young KA, Engelman CD, Langefeld CD, et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 2009; 94(9): 3306-13.
[http://dx.doi.org/10.1210/jc.2009-0079] [PMID: 19549738]
[13]
Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 2001; 358(9292): 1500-3.
[http://dx.doi.org/10.1016/S0140-6736(01)06580-1] [PMID: 11705562]
[14]
Hossein-nezhad A, Holick MF. Vitamin D for health: A global perspective. Mayo Clin Proc 2013; 88(7): 720-55.
[http://dx.doi.org/10.1016/j.mayocp.2013.05.011] [PMID: 23790560]
[15]
Pludowski P, Holick MF, Grant WB, et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol 2018; 175: 125-35.
[http://dx.doi.org/10.1016/j.jsbmb.2017.01.021] [PMID: 28216084]
[16]
Zittermann A, Ernst JB, Gummert JF, Börgermann J. Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: A systematic review. Eur J Nutr 2014; 53(2): 367-74.
[http://dx.doi.org/10.1007/s00394-013-0634-3] [PMID: 24292820]
[17]
Holick MF, Vitamin D. Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79(3): 362-71.
[http://dx.doi.org/10.1093/ajcn/79.3.362] [PMID: 14985208]
[18]
Pilz S, Trummer C, Pandis M, et al. Vitamin D: Current Guidelines and Future Outlook. Anticancer Res 2018; 38(2): 1145-51.
[PMID: 29374751]
[19]
BS O. Metabolismo del calcio, fósforo y magnesio. Manual de enfermedades óseas2 ed: Sociedad Española de Reumatología;. 2010.
[20]
Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81(3): 353-73.
[http://dx.doi.org/10.4065/81.3.353] [PMID: 16529140]
[21]
DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80(6)(Suppl.): 1689S-96S.
[http://dx.doi.org/10.1093/ajcn/80.6.1689S] [PMID: 15585789]
[22]
Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007; 176(2): 208-13.
[http://dx.doi.org/10.1164/rccm.200701-007OC] [PMID: 17463418]
[23]
van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 2011; 25(4): 671-80.
[http://dx.doi.org/10.1016/j.beem.2011.06.007] [PMID: 21872807]
[24]
Holick MF, Chen TC. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008; 87(4): 1080S-6S.
[http://dx.doi.org/10.1093/ajcn/87.4.1080S] [PMID: 18400738]
[25]
Strange RC, Shipman KE, Ramachandran S. Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. World J Diabetes 2015; 6(7): 896-911.
[http://dx.doi.org/10.4239/wjd.v6.i7.896] [PMID: 26185598]
[26]
Shahar DR, Schwarzfuchs D, Fraser D, et al. Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr 2010; 92(5): 1017-22.
[http://dx.doi.org/10.3945/ajcn.2010.29355] [PMID: 20810979]
[27]
Renzaho AM, Halliday JA, Nowson C. Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: A systematic review. Nutrition 2011; 27(9): 868-79.
[http://dx.doi.org/10.1016/j.nut.2010.12.014] [PMID: 21704500]
[28]
Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988; 67(2): 373-8.
[http://dx.doi.org/10.1210/jcem-67-2-373] [PMID: 2839537]
[29]
Mora N, Rieke K, Plitcha J, et al. 25-hydroxyvitamin D supplementation and BMI change: A meta-analysis of randomized controlled trials. J Obes Weight Loss Ther 2013; 3(4): 181.
[PMID: 25632374]
[30]
Dhaliwal R, Mikhail M, Feuerman M, Aloia JF. The vitamin d dose response in obesity. Endocr Pract 2014; 20(12): 1258-64.
[http://dx.doi.org/10.4158/EP13518.OR] [PMID: 25100366]
[31]
Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76(1): 370-3.
[http://dx.doi.org/10.1172/JCI111971] [PMID: 2991340]
[32]
Vimaleswaran KS, Berry DJ, Lu C, et al. Genetic Investigation of Anthropometric Traits-GIANT Consortium. Causal relationship between obesity and vitamin D status: Bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013; 10(2)e1001383
[http://dx.doi.org/10.1371/journal.pmed.1001383] [PMID: 23393431]
[33]
Carrillo AE, Flynn MG, Pinkston C, et al. Impact of vitamin D supplementation during a resistance training intervention on body composition, muscle function, and glucose tolerance in overweight and obese adults. Clin Nutr 2013; 32(3): 375-81.
[http://dx.doi.org/10.1016/j.clnu.2012.08.014] [PMID: 23034474]
[34]
Goswami R, Gupta N, Ray D, Singh N, Tomar N. Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D. Br J Nutr 2008; 100(3): 526-9.
[http://dx.doi.org/10.1017/S0007114508921711] [PMID: 18252022]
[35]
Jamka M, Woźniewicz M, Walkowiak J, Bogdański P, Jeszka J, Stelmach-Mardas M. The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: A systematic review with meta-analysis. Eur J Nutr 2016; 55(6): 2163-76.
[http://dx.doi.org/10.1007/s00394-015-1089-5] [PMID: 26538075]
[36]
Bolland MJ, Grey AB, Ames RW, et al. Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clin Endocrinol (Oxf) 2007; 67(2): 259-64.
[http://dx.doi.org/10.1111/j.1365-2265.2007.02873.x] [PMID: 17547688]
[37]
Vanlint S. Vitamin D and obesity. Nutrients 2013; 5(3): 949-56.
[http://dx.doi.org/10.3390/nu5030949] [PMID: 23519290]
[38]
Wamberg L, Kampmann U, Stødkilde-Jørgensen H, Rejnmark L, Pedersen SB, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med 2013; 24(7): 644-9.
[http://dx.doi.org/10.1016/j.ejim.2013.03.005] [PMID: 23566943]
[39]
Forsythe LK, Livingstone MB, Barnes MS, et al. Effect of adiposity on vitamin D status and the 25-hydroxycholecalciferol response to supplementation in healthy young and older Irish adults. Br J Nutr 2012; 107(1): 126-34.
[http://dx.doi.org/10.1017/S0007114511002662] [PMID: 21733320]
[40]
Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes 2010; 59(1): 242-8.
[http://dx.doi.org/10.2337/db09-1011] [PMID: 19833894]
[41]
Kull M, Kallikorm R, Lember M. Body mass index determines sunbathing habits: Implications on vitamin D levels. Intern Med J 2009; 39(4): 256-8.
[http://dx.doi.org/10.1111/j.1445-5994.2009.01900.x] [PMID: 19402866]
[42]
Harris SS, Dawson-Hughes B. Reduced sun exposure does not explain the inverse association of 25-hydroxyvitamin D with percent body fat in older adults. J Clin Endocrinol Metab 2007; 92(8): 3155-7.
[http://dx.doi.org/10.1210/jc.2007-0722] [PMID: 17535990]
[43]
Chen WR, Qian YA, Chen YD, et al. The effects of low vitamin D on coronary artery disease. Heart Lung Circ 2014; 23(4): 314-9.
[http://dx.doi.org/10.1016/j.hlc.2013.08.012] [PMID: 24161735]
[44]
Florez H, Martinez R, Chacra W, Strickman-Stein N, Levis S. Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J Steroid Biochem Mol Biol 2007; 103(3-5): 679-81.
[http://dx.doi.org/10.1016/j.jsbmb.2006.12.032] [PMID: 17267209]
[45]
Hewitt S, Søvik TT, Aasheim ET, et al. Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch. Obes Surg 2013; 23(3): 384-90.
[http://dx.doi.org/10.1007/s11695-012-0772-3] [PMID: 23015268]
[46]
Chandler PD, Scott JB, Drake BF, et al. Impact of vitamin D supplementation on adiposity in African-Americans. Nutr Diabetes 2015; 5e164
[http://dx.doi.org/10.1038/nutd.2015.14] [PMID: 26075641]
[47]
Shapses SA, Sukumar D, Schneider SH, Schlussel Y, Brolin RE, Taich L. Hormonal and dietary influences on true fractional calcium absorption in women: Role of obesity. Osteoporos Int 2012; 23(11): 2607-14.
[http://dx.doi.org/10.1007/s00198-012-1901-5] [PMID: 22282301]
[48]
Rosenstreich SJ, Rich C, Volwiler W. Deposition in and release of vitamin D3 from body fat: Evidence for a storage site in the rat. J Clin Invest 1971; 50(3): 679-87.
[http://dx.doi.org/10.1172/JCI106538] [PMID: 4322721]
[49]
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72(3): 690-3.
[http://dx.doi.org/10.1093/ajcn/72.3.690] [PMID: 10966885]
[50]
Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Lawless A. Effects of vitamin D supplementation on 25-hydroxyvitamin D, high-density lipoprotein cholesterol, and other cardiovascular disease risk markers in subjects with elevated waist circumference. Int J Food Sci Nutr 2011; 62(4): 318-27.
[http://dx.doi.org/10.3109/09637486.2010.536146] [PMID: 21250901]
[51]
Blum M, Dallal GE, Dawson-Hughes B. Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr 2008; 27(2): 274-9.
[http://dx.doi.org/10.1080/07315724.2008.10719700] [PMID: 18689559]
[52]
Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G. Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: The Tromsø study. Eur J Nutr 2010; 49(7): 401-7.
[http://dx.doi.org/10.1007/s00394-010-0098-7] [PMID: 20204652]
[53]
Guasch A, Bulló M, Rabassa A, et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: A cross-sectional study. Cardiovasc Diabetol 2012; 11: 149.
[http://dx.doi.org/10.1186/1475-2840-11-149] [PMID: 23228198]
[54]
Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study. Eur J Endocrinol 2004; 151(2): 167-72.
[http://dx.doi.org/10.1530/eje.0.1510167] [PMID: 15296470]
[55]
Zhu W, Cai D, Wang Y, et al. Calcium plus vitamin D3 supplementation facilitated fat loss in overweight and obese college students with very-low calcium consumption: A randomized controlled trial. Nutr J 2013; 12: 8.
[http://dx.doi.org/10.1186/1475-2891-12-8] [PMID: 23297844]
[56]
Teegarden D, White KM, Lyle RM, et al. Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 2008; 16(7): 1566-72.
[http://dx.doi.org/10.1038/oby.2008.232] [PMID: 18421269]
[57]
Major GC, Alarie FP, Doré J, Tremblay A. Calcium plus vitamin D supplementation and fat mass loss in female very low-calcium consumers: Potential link with a calcium-specific appetite control. Br J Nutr 2009; 101(5): 659-63.
[http://dx.doi.org/10.1017/S0007114508030808] [PMID: 19263591]
[58]
Rosenblum JL, Castro VM, Moore CE, Kaplan LM. Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am J Clin Nutr 2012; 95(1): 101-8.
[http://dx.doi.org/10.3945/ajcn.111.019489] [PMID: 22170363]
[59]
Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116(1): 39-48.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.106.675355] [PMID: 17576866]
[60]
Zhou J, Zhao LJ, Watson P, Zhang Q, Lappe JM. The effect of calcium and vitamin D supplementation on obesity in postmenopausal women: Secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial. Nutr Metab (Lond) 2010; 7: 62.
[http://dx.doi.org/10.1186/1743-7075-7-62] [PMID: 20650013]
[61]
Soares MJ, Murhadi LL, Kurpad AV, Chan She Ping-Delfos WL, Piers LS. Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obes Rev 2012; 13(7): 592-605.
[http://dx.doi.org/10.1111/j.1467-789X.2012.00986.x] [PMID: 22385576]
[62]
Kabrnová-Hlavatá K, Hainer V, Gojová M, et al. Calcium intake and the outcome of short-term weight management. Physiol Res 2008; 57(2): 237-45.
[PMID: 17552880]
[63]
Salehpour A, Hosseinpanah F, Shidfar F, et al. A 12-week double-blind randomized clinical trial of vitamin D3 supplementation on body fat mass in healthy overweight and obese women. Nutr J 2012; 11: 78.
[http://dx.doi.org/10.1186/1475-2891-11-78] [PMID: 22998754]
[64]
Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 2008; 159(6): 675-84.
[http://dx.doi.org/10.1530/EJE-08-0339] [PMID: 19056900]
[65]
Blum M, Dolnikowski G, Seyoum E, et al. Vitamin D(3) in fat tissue. Endocrine 2008; 33(1): 90-4.
[http://dx.doi.org/10.1007/s12020-008-9051-4] [PMID: 18338271]
[66]
Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95(2): 471-8.
[http://dx.doi.org/10.1210/jc.2009-1773] [PMID: 20133466]
[67]
Nesby-O’Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002; 76(1): 187-92.
[http://dx.doi.org/10.1093/ajcn/76.1.187] [PMID: 12081833]
[68]
Rock CL, Emond JA, Flatt SW, et al. Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity (Silver Spring) 2012; 20(11): 2296-301.
[http://dx.doi.org/10.1038/oby.2012.57] [PMID: 22402737]
[69]
Wu SH, Ho SC, Zhong L. Effects of vitamin D supplementation on blood pressure. South Med J 2010; 103(8): 729-37.
[http://dx.doi.org/10.1097/SMJ.0b013e3181e6d389] [PMID: 20622727]
[70]
Mason C, Xiao L, Imayama I, et al. Vitamin D3 supplementation during weight loss: A double-blind randomized controlled trial. Am J Clin Nutr 2014; 99(5): 1015-25.
[http://dx.doi.org/10.3945/ajcn.113.073734] [PMID: 24622804]
[71]
Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89(5): 1321-7.
[http://dx.doi.org/10.3945/ajcn.2008.27004] [PMID: 19321573]
[72]
Mousa A, Naderpoor N, de Courten MP, et al. Vitamin D supplementation has no effect on insulin sensitivity or secretion in vitamin D-deficient, overweight or obese adults: A randomized placebo-controlled trial. Am J Clin Nutr 2017; 105(6): 1372-81.
[http://dx.doi.org/10.3945/ajcn.117.152736] [PMID: 28490514]
[73]
Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009; 26(1): 19-27.
[http://dx.doi.org/10.1111/j.1464-5491.2008.02636.x] [PMID: 19125756]
[74]
Sun Q, Shi L, Rimm EB, et al. Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr 2011; 94(2): 534-42.
[http://dx.doi.org/10.3945/ajcn.110.008763] [PMID: 21653796]
[75]
Forman JP, Scott JB, Ng K, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 2013; 61(4): 779-85.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.00659] [PMID: 23487599]
[76]
Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49(5): 1063-9.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.087288] [PMID: 17372031]
[77]
Al-Daghri NM, Alkharfy KM, Al-Saleh Y, et al. Modest reversal of metabolic syndrome manifestations with vitamin D status correction: A 12-month prospective study. Metabolism 2012; 61(5): 661-6.
[http://dx.doi.org/10.1016/j.metabol.2011.09.017] [PMID: 22075268]
[78]
Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: Meta-analysis of 283,537 participants. Eur J Epidemiol 2013; 28(3): 205-21.
[http://dx.doi.org/10.1007/s10654-013-9790-2] [PMID: 23456138]
[79]
Prasad P, Kochhar A. Interplay of vitamin D and metabolic syndrome: A review. Diabetes Metab Syndr 2016; 10(2): 105-12.
[http://dx.doi.org/10.1016/j.dsx.2015.02.014] [PMID: 25813139]
[80]
Beveridge LA, Struthers AD, Khan F, et al. Effect of vitamin D supplementation on blood pressure: A systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med 2015; 175(5): 745-54.
[http://dx.doi.org/10.1001/jamainternmed.2015.0237] [PMID: 25775274]
[81]
Luhovyy BL, Akhavan T, Anderson GH. Whey proteins in the regulation of food intake and satiety. J Am Coll Nutr 2007; 26(6): 704S-12S.
[http://dx.doi.org/10.1080/07315724.2007.10719651] [PMID: 18187437]
[82]
Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010; 267(5): 462-72.
[http://dx.doi.org/10.1111/j.1365-2796.2009.02181.x] [PMID: 20141565]
[83]
McMullan CJ, Borgi L, Curhan GC, Fisher N, Forman JP. The effect of vitamin D on renin-angiotensin system activation and blood pressure: A randomized control trial. J Hypertens 2017; 35(4): 822-9.
[http://dx.doi.org/10.1097/HJH.0000000000001220] [PMID: 28033130]
[84]
Carrara D, Bernini M, Bacca A, et al. Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. J Renin Angiotensin Aldosterone Syst 2014; 15(1): 82-7.
[http://dx.doi.org/10.1177/1470320312471149] [PMID: 23283825]
[85]
Kota SK, Kota SK, Jammula S, et al. Renin-angiotensin system activity in vitamin D deficient, obese individuals with hypertension: An urban Indian study. Indian J Endocrinol Metab 2011; 15(Suppl. 4): S395-401.
[http://dx.doi.org/10.4103/2230-8210.86985] [PMID: 22145146]
[86]
Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 2011; 50(4): 303-12.
[http://dx.doi.org/10.1016/j.plipres.2011.05.001] [PMID: 21640757]
[87]
Karhapää P, Pihlajamäki J, Pörsti I, et al. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med 2010; 268(6): 604-10.
[http://dx.doi.org/10.1111/j.1365-2796.2010.02279.x] [PMID: 20831628]
[88]
Fu J, Han L, Zhao Y, et al. Vitamin D levels are associated with metabolic syndrome in adolescents and young adults: The BCAMS study. Clin Nutr 2018; 30: 1-7.
[http://dx.doi.org/10.1016/j.clnu.2018.08.039] [PMID: 30236482]
[89]
Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW. Vitamin D may not improve lipid levels: A serial clinical laboratory data study. Circulation 2012; 126(3): 270-7.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.077875] [PMID: 22718799]
[90]
Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials. Lipids Health Dis 2012; 11: 42.
[http://dx.doi.org/10.1186/1476-511X-11-42] [PMID: 22433171]
[91]
Major GC, Alarie F, Doré J, Phouttama S, Tremblay A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007; 85(1): 54-9.
[PMID: 17209177]
[92]
Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: A new and important cardiovascular risk factor? Eur Heart J 2012; 33(10): 1190-200.
[http://dx.doi.org/10.1093/eurheartj/ehr453] [PMID: 22408036]
[93]
Roth CL, Elfers CT, Figlewicz DP, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology 2012; 55(4): 1103-11.
[http://dx.doi.org/10.1002/hep.24737] [PMID: 21994008]
[94]
Sun X, Cao ZB, Tanisawa K, Ito T, Oshima S, Higuchi M. Vitamin D supplementation reduces insulin resistance in Japanese adults: A secondary analysis of a double-blind, randomized, placebo-controlled trial. Nutr Res 2016; 36(10): 1121-9.
[http://dx.doi.org/10.1016/j.nutres.2016.07.006] [PMID: 27865354]
[95]
Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30(4): 980-6.
[http://dx.doi.org/10.2337/dc06-1994] [PMID: 17277040]
[96]
Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care 2013; 36(5): 1361-7.
[http://dx.doi.org/10.2337/dc12-1050] [PMID: 23393216]
[97]
Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152(5): 307-14.
[http://dx.doi.org/10.7326/0003-4819-152-5-201003020-00009] [PMID: 20194237]
[98]
Harris SS, Pittas AG, Palermo NJ. A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab 2012; 14(9): 789-94.
[http://dx.doi.org/10.1111/j.1463-1326.2012.01605.x] [PMID: 22486948]
[99]
von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 2010; 103(4): 549-55.
[http://dx.doi.org/10.1017/S0007114509992017] [PMID: 19781131]
[100]
Alvarez JA, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010; 2010351385
[http://dx.doi.org/10.1155/2010/351385] [PMID: 20011094]
[101]
Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine 2012; 60(3): 870-4.
[http://dx.doi.org/10.1016/j.cyto.2012.07.032] [PMID: 22925537]
[102]
Tepper S, Shahar DR, Geva D, Ish-Shalom S. Differences in Homeostatic Model Assessment (HOMA) values and insulin levels after vitamin D supplementation in healthy men: A double-blind randomized controlled trial. Diabetes Obes Metab 2016; 18(6): 633-7.
[http://dx.doi.org/10.1111/dom.12650] [PMID: 26890031]
[103]
Wood AD, Secombes KR, Thies F, et al. A parallel group double-blind RCT of vitamin D3 assessing physical function: Is the biochemical response to treatment affected by overweight and obesity? Osteoporos Int 2014; 25(1): 305-15.
[http://dx.doi.org/10.1007/s00198-013-2473-8] [PMID: 23982800]
[104]
Yin X, Yan L, Lu Y, Jiang Q, Pu Y, Sun Q. Correction of hypovitaminosis D does not improve the metabolic syndrome risk profile in a Chinese population: A randomized controlled trial for 1 year. Asia Pac J Clin Nutr 2016; 25(1): 71-7.
[http://dx.doi.org/10.6133/apjcn.2016.25.1.06] [PMID: 26965764]
[105]
Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013; 36(2): 260-6.
[http://dx.doi.org/10.2337/dc12-1204] [PMID: 23033239]
[106]
George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: A systematic review and meta-analysis. Diabet Med 2012; 29(8): E142-50.
[http://dx.doi.org/10.1111/j.1464-5491.2012.03672.x] [PMID: 22486204]
[107]
Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: A systematic review. Eur J Clin Nutr 2011; 65(9): 1005-15.
[http://dx.doi.org/10.1038/ejcn.2011.118] [PMID: 21731035]
[108]
Seida JC, Mitri J, Colmers IN, et al. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: A systematic review and meta-analysis. J Clin Endocrinol Metab 2014; 99(10): 3551-60.
[http://dx.doi.org/10.1210/jc.2014-2136] [PMID: 25062463]
[109]
Poolsup N, Suksomboon N, Plordplong N. Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: A systematic review and meta-analysis. Diabet Med 2016; 33(3): 290-9.
[http://dx.doi.org/10.1111/dme.12893] [PMID: 26308752]
[110]
Shieh A, Ma C, Chun RF, et al. Effects of cholecalciferol vs calcifediol on total and free 25-hydroxyvitamin D and parathyroid hormone. J Clin Endocrinol Metab 2017; 102(4): 1133-40.
[http://dx.doi.org/10.1210/jc.2016-3919] [PMID: 28187226]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 22
Year: 2019
Published on: 26 September, 2019
Page: [2407 - 2420]
Pages: 14
DOI: 10.2174/1381612825666190722103919
Price: $65

Article Metrics

PDF: 44
HTML: 4
EPUB: 1